QUOTE AND NEWS
MedPage Today  Jul 25  Comment 
(MedPage Today) -- This week, Friday Feedback takes a look at The BMJ's investigation into alleged suppression of information supporting routine drug level monitoring and dose adjustment for dabigatran (Pradaxa).
FiercePharma  Jul 24  Comment 
The BMJ has set off a kerfuffle--and a Twitter campaign--over the safety of Boehringer Ingelheim's blockbuster anticoagulant Pradaxa.
Forbes  Jul 23  Comment 
Once again dabigatran (Pradaxa) has raised the wrath of the critics. Several articles and an editorial published today in The BMJ raise more questions and concerns about the drug, which is the first of the new oral anticoagulants. Relying on...
MedPage Today  Jun 16  Comment 
(MedPage Today) -- Emergency physician David Newman, MD, says a BMJ study that linked salt intake reduction with stroke and cardiovascular mortality has a fatal flaw.
FierceBiotech  May 30  Comment 
As Europe prepares to open its clinical trial data vaults in a move toward greater transparency, the British Medical Journal is criticizing the European Medicines Agency for seemingly backtracking on its promises to make important information...
Forbes  May 19  Comment 
The BMJ has released the names of an outside expert panel who will decide the fate of two articles that are the subject of a heated dispute.
MedPage Today  May 19  Comment 
(MedPage Today) -- BMJ released on Monday the roster of an independent panel charged with deciding whether two papers containing inaccurate statements about the risks of statins should be retracted.
Forbes  May 14  Comment 
The authors of two BMJ articles have withdrawn statements about the adverse effects of statins. The two papers inaccurately cite an earlier publication and therefore overstate the incidence of adverse effects of statins. As a result, the two...
Forbes  Apr 28  Comment 
For more than a decade cardiac stem cell therapy has attracted an enormous amount of attention, promise, and research dollars. Now an original and important new study published in BMJ finds that many of the most promising results in the field are...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki